Rx Response To Global HIV Must Be Stronger To Save IP System – Kessler
Pharmaceutical manufacturers need to do more than rely on President Bush's global AIDS relief initiative if they want to protect the international patent system, former FDA commissioner David Kessler says
You may also be interested in...
The Pharmaceutical Research & Manufacturers of America expects TRIPS negotiations on the importation of drugs made under compulsory license to resume within several weeks
The World Trade Organization declaration on pharmaceutical patents includes language encouraging developed countries to provide incentives to industry to improve public health in developing nations
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011